<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:mp ids='MP_0009308'>Adenocarcinoma</z:mp> of the esophago-gastric junction (EGJ) potentially spreads to abdominal and mediastinal lymph nodes </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Eighty-five patients with type I and II EGJ <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> underwent curative esophagectomy or esophago-gastrectomy and radical abdominal and mediastinal lymphadenectomy </plain></SENT>
<SENT sid="2" pm="."><plain>Microinvolvement was detected with the mAb Ber-Ep4 in <z:hpo ids='HP_0000001'>all</z:hpo> histopathologically free lymph nodes </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In type I <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (n = 40), lower mediastinal lymph nodes were positive in 24% and among type II <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (n = 45) in 10% of patients </plain></SENT>
<SENT sid="4" pm="."><plain>Ber-Ep4+ cells in apparently free lymph nodes were found in 49% of patients </plain></SENT>
<SENT sid="5" pm="."><plain>On inclusion of Ber-Ep4+ nodes, positive mediastinal lymph node staging was rising to 40 and 33% in type I and II patients, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>After a median observation time of 27.1 months, 37 of 85 patients (43.5%) had died of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> disease </plain></SENT>
<SENT sid="7" pm="."><plain>Kaplan-Meier analysis revealed a significant impact of nodal microinvolvement on disease-specific survival for type I and type II <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (P = 0.016 and P &lt; 0.001, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>Cox regression analysis revealed a 2.77 higher independent risk (P = 0.002) for nodal microinvolvement </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Lymphatic microinvolvement shows a high incidence in curatively resected EGJ <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Spread to mediastinal lymph nodes seems to necessitate lymphadenectomy of the thoracic cavity in either type </plain></SENT>
</text></document>